Home/Filings/4/0001127602-24-010850
4//SEC Filing

Graham Jonathan P 4

Accession 0001127602-24-010850

CIK 0000318154other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 8:04 PM ET

Size

5.5 KB

Accession

0001127602-24-010850

Insider Transaction Report

Form 4
Period: 2024-03-18
Graham Jonathan P
EVP & Gen. Counsel & Secy.
Transactions
  • Tax Payment

    Common Stock

    2024-03-18$268.87/sh5,879$1,580,68734,232 total
Footnotes (2)
  • [F1]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,122 RSUs which will vest on 5/5/2024; 2,544 RSUs which will vest in installments of 1,253 on 4/30/2024 and 1,291 on 4/30/2025; 3,377 RSUs which will vest in two installments of 1,114 each on 5/2/2024 and 5/2/2025, and one installment of 1,149 on 5/2/2026; and 3,390 RSUs which will vest in installments of 1,118 on 5/2/2025, 1,119 on 5/2/2026 and 1,153 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F2]These shares include 756 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeother

Related Parties

1
  • filerCIK 0001365306

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 8:04 PM ET
Size
5.5 KB